It was associated with increased risk of conversion from clinically isolated syndrome to RRMS.17 This glycoprotein is increased in patients with SPMS and also in the CSF of patients with active RRMS, suggesting that elevated fetuin A is potentially useful as a marker of MS activity.18,19. This evidence concerns the gene AHSG and myeloid sarcoma.